Moreover, mutation carriers opting for prophylactic mastectomy are more often in their thirties, more often have young children, and also have a greater awareness of the genetic nature of cancer in the family than those opting for regular surveillance.
Moreover, SMAD3 mutation carriers are more susceptible to early sudden death due to aortic dissection and/or rupture, which often occurs in a mildly dilated aorta [ 5].
Moreover, BRCA1 germline mutation carriers are not only at risk of ovarian cancer, but also fallopian tube carcinoma and peritoneal papillary serous carcinoma[ 31].
Moreover, all BRCA1 mutation carriers were identified by using IHC screening, thus confirming that the Allred's method can be used to accurately predict the probability of being a carrier of the BRCA1 mutation.
Moreover, BRCA1 and BRCA2 mutation carriers are also at increased risk of pancreatic, prostate, and endometrial cancer.
Moreover, many of the mutation carriers had family history of various cancer types, including for instance colon and prostate cancer.
Moreover, tumors arising in BRCA1 mutation carriers illustrate sensitivity to poly- ADP -ribose poly- ADP -ribosetors, thus suggesting that mutated BRCA1 within TNBC could be poly- ADP -ribosepolymerasehinhibitorslass of agenthus 19, 20].
Moreover, breast cancer risks for mutation carriers were found to vary according to the age at diagnosis and the type of cancer of the index patient involved in the family ascertainment [ 6, 7, 11].
Other investigators did not find any significant survival difference in BRCA mutation carriers compared with non-carrier cases [ 20, 21]; moreover, breast cancer specific mortality rates have been found similar for BRCA mutation carriers and non-carriers in Jewish population [ 22].
Moreover, although overall life expectancy in BRCA1/2 mutation carriers has been estimated, using simulation models, to be decreased [14], the actual impact of having a BRCA1/2 mutation on life expectancy is not known.
